RT Journal Article
T1 Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN).
A1 Guevara, Marcela
A1 Molinuevo, Amaia
A1 Salmeron, Diego
A1 Marcos-Gragera, Rafael
A1 Carulla, Maria
A1 Chirlaque, Maria-Dolores
A1 Rodriguez Camblor, Marta
A1 Aleman, Araceli
A1 Rojas, Dolores
A1 Vizcaino Batlles, Ana
A1 Chico, Matilde
A1 Jimenez Chillaron, Rosario
A1 Lopez de Munain, Arantza
A1 de Castro, Visitacion
A1 Sanchez-Perez, Maria-Jose
A1 Ramalle-Gomara, Enrique
A1 Franch, Paula
A1 Galceran, Jaume
A1 Ardanaz, Eva
K1 cancer
K1 cancer registries
K1 epidemiology
K1 population-based study
K1 prognosis
K1 survival
AB The assessment of cancer survival at the population level is essential for monitoring progress in cancer control. We aimed to assess cancer survival and its trends in adults in Spain. Individual records of 601,250 adults with primary cancer diagnosed during 2002-2013 and followed up to 2015 were included from 13 population-based cancer registries. We estimated net survival up to five years after diagnosis and analyzed absolute changes between 2002-2007 and 2008-2013. Estimates were age-standardized. Analyses were performed for 29 cancer groups, by age and sex. Overall, age-standardized five-year net survival was higher in women (61.7%, 95% CI 61.4-62.1%) than in men (55.3%, 95% CI 55.0-55.6%), and ranged by cancer from 7.2% (pancreas) to 89.6% (prostate) in men, and from 10.0% (pancreas) to 93.1% (thyroid) in women in the last period. Survival declined with age, showing different patterns by cancer. Between both periods, age-standardized five-year net survival increased overall by 3.3% (95% CI 3.0-3.7%) in men and 2.5% (95% CI 2.0-3.0%) in women, and for most cancer groups. Improvements were greater in patients younger than 75 years than in older patients. Chronic myeloid leukemia and myeloma showed the largest increases. Among the most common malignancies, the greatest absolute increases in survival were observed for colon (5.0%, 95% CI 4.0-6.0%) and rectal cancers (4.5%, 95% CI 3.2-5.9%). Survival improved even for some cancers with poor prognosis (pancreas, esophagus, lung, liver, and brain cancer). Further investigation of possible sociodemographic inequalities is warranted. This study contributes to the evaluation of cancer control and health services' effectiveness.
PB MDPI AG
SN 2072-6694
YR 2022
FD 2022-05-13
LK http://hdl.handle.net/10668/20894
UL http://hdl.handle.net/10668/20894
LA en
NO Guevara M, Molinuevo A, Salmerón D, Marcos-Gragera R, Carulla M, Chirlaque MD, et al. Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN). Cancers (Basel). 2022 May 15;14(10):2441.
DS RISalud
RD Apr 6, 2025